TLGT Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (1 янв. 1970 @ 03:00):

Stats
Объем за сегодня	72.25M
Средний объем	7.97M
Рыночная капитализация	0.00
EPS	$-0.140 ( 2021-08-16 )
Last Dividend	$47.50 ( 1995-12-13 )
Next Dividend	$0 ( N/A )
P/E	-0.0403
ATR14	$0.0270 (15.56%)

Insider Trading

Date	Person	Action	Amount	type
2021-07-21	Ben-maimon Carole	Buy	150 000	Restricted Stock Units
2021-07-21	Celentano John E	Buy	150 000	Restricted Stock Units
2021-07-21	Marth William S	Buy	150 000	Restricted Stock Units
2021-07-21	Pate R Carter	Buy	150 000	Restricted Stock Units
2021-07-16	Yachmetz Philip K	Buy	7 835	Restricted Stock Units

INSIDER POWER
0.00
Last 94 transactions
Buy: 6 929 847 \| Sell: 975 703

Объем Корреляция

Длинно: -0.41 (neutral)

Кратко: -0.94 (very strong negative)

Signal:(21.732) Possible Trading Opportunity Present (swing)

Teligent Inc (NEW JERSEY) Корреляция

10 Самые положительные корреляции
SVAC	0.953
PAIC	0.934
RMRM	0.914
GOODM	0.907
MTSL	0.856
SPRT	0.848
FEYE	0.842

10 Самые отрицательные корреляции
NETE	-0.948
AMRB	-0.934
MMAC	-0.907
LWAC	-0.883
RAVN	-0.872
SRAC	-0.862
BOCH	-0.804

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Teligent Inc (NEW JERSEY) Корреляция - Валюта/Сырье

-0.81
( strong negative )

-0.75
( moderate negative )

0.00
( neutral )

-0.76
( moderate negative )

-0.50
( neutral )

0.47
( neutral )

Teligent Inc (NEW JERSEY) Финансовые показатели

Annual	2020
Выручка:	$45.31M
Валовая прибыль:	$45.31M (100.00 %)
EPS:	$0

FY	2020
Выручка:	$45.31M
Валовая прибыль:	$45.31M (100.00 %)
EPS:	$0

FY	2019
Выручка:	$65.90M
Валовая прибыль:	$23.52M (35.70 %)
EPS:	$-4.70

FY	2017
Выручка:	$67.25M
Валовая прибыль:	$27.37M (40.70 %)
EPS:	$-2.80

Financial Reports:

No articles found.

Teligent Inc (NEW JERSEY) Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Teligent Inc (NEW JERSEY) Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - N/A | Divividend Growth Potential Score: 0 - N/A

Information

First Dividend	$47.50	1995-12-13
Last Dividend	$47.50	1995-12-13
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	$47.50	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0
Div. Directional Score	0	--

Next Divdend (Est)
(2024-04-27)

$0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
1995	$0	0.00%
1996	$0	0.00%
1997	$0	0.00%
1998	$0	0.00%
1999	$0	0.00%
2000	$0	0.00%
2001	$0	0.00%
2002	$0	0.00%
2003	$0	0.00%
2004	$0	0.00%
2005	$0	0.00%
2006	$0	0.00%
2007	$0	0.00%
2008	$0	0.00%
2009	$0	0.00%
2010	$0	0.00%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

Unable to generate commentary due to missing data.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0	1.500	0	0	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0	1.500	-1.111	-1.667	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.916	0.800	5.42	4.34	[1 - 3]
quickRatioTTM	0.744	0.800	-0.329	-0.263	[0.8 - 2.5]
cashRatioTTM	0.257	1.500	9.68	10.00	[0.2 - 2]
debtRatioTTM	1.636	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.217	2.00	-0.0725	-0.145	[0 - 30]
freeCashFlowPerShareTTM	-0.270	2.00	-0.135	-0.270	[0 - 20]
debtEquityRatioTTM	-1.246	-1.500	-4.98	7.47	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.988	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.122	1.000	-1.790	-1.790	[0.2 - 2]
assetTurnoverTTM	0.540	0.800	9.73	7.79	[0.5 - 2]
Total Score				3.69

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	0	1.000	-0.101	0	[1 - 100]
returnOnEquityTTM	0	2.50	-0.714	-1.667	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.270	2.00	-0.0899	-0.270	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.217	2.00	-0.0725	-0.145	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.370	1.000	-10.00	0	[0.1 - 0.5]
Total Score				-1.721

Teligent Inc (NEW JERSEY)

Teligent, Inc., formerly Igi Laboratories Inc, is a specialty generic pharmaceutical company. Under the Company's own label, it markets and sells generic injectable pharmaceutical products in the United States and Canada. In the United States it marketed 35 generic topical pharmaceutical products and four branded generic pharmaceutical products, as of December 31, 2018. It provides development, formulation and manufacturing services to the pharmaceutical, over-the-counter (OTC) and cosmetic industries. It focuses on developing, manufacturing and marketing a portfolio of generic pharmaceutical products under its own label in topical, injectable, complex and ophthalmic dosage forms, and managing its contract manufacturing and formulation services business. Its pipeline included 20 Abbreviated New Drug Application (ANDAs) filed with the United States Food and Drug Administration (FDA) for additional pharmaceutical products, as of December 31, 2018.